Eli Lilly targets India as global supply chain hub for blockbuster drugs

The drugmaker plans to turn India into a global export hub using a billion-dollar investment. This follows surging Mounjaro sales and plans for new treatments.

洞察:
Eli Lilly and Company announced on February 17, 2026, its plan to establish India ININ as a hub for its global supply chain. This initiative is part of a previously committed $1 billion investment in the contract manufacturing sector in India. The United States USUS-based pharmaceutical firm aims to export locally produced drugs worldwide, leveraging India's contract-manufacturing capacity to reshape its supply and distribution for key products.
Visitors stand at the kiosk of Eli Lilly at the BioAsia conference in Hyderabad, India, February 17, 2026. Picture taken with a mobile phone. REUTERS/Sriparna Roy
Visitors stand at the kiosk of Eli Lilly at the BioAsia conference in Hyderabad, India, February 17, 2026. Picture taken with a mobile phone. REUTERS/Sriparna Roy